Skip to main content

BioSyent to Acquire Oral Science Inc.

Accretive Transaction with Combined Companies’ Pro-Forma Revenue in Excess of $70.00 Million and EBITDA(1) in Excess of $15.75 Million (TTM Sept 30, 2025) MISSISSAUGA, Ontario, Feb. 09, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) announced today that it has entered into a Share Purchase Agreement (“SPA”) dated February 8, 2026 to acquire Oral Science Inc. (“Oral Science”), a privately-owned Canadian distributor of specialized healthcare products for dental hygiene and oral health based in Brossard, Quebec.   THE TRANSACTION Pursuant to the SPA, BioSyent will acquire from the shareholders of Oral Science (the “Sellers”), in an arm’s length transaction, 100% of the issued and outstanding shares of Oral Science Inc. for a $25.5 million purchase price consisting of $22.5 million of cash and 234,192 BioSyent...

Continue reading

Transocean to Acquire Valaris

Creates the world’s highest-quality, highest-specification offshore drilling fleet Companies to host conference call today at 8 a.m. CT / 9 a.m. ET STEINHAUSEN, Switzerland and HAMILTON, Bermuda, Feb. 09, 2026 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) and Valaris Limited (NYSE: VAL) today announced the signing of a definitive agreement to combine the two companies under which Transocean will acquire Valaris in an all-stock transaction valued at approximately $5.8 billion (all currency in USD). The shareholding percentages of the combined company, on a fully diluted basis1, will be approximately 53% for Transocean and 47% for Valaris. The enterprise value of the pro forma company is approximately $17 billion. HighlightsCreates an industry leader with a diversified offshore fleet of 73 rigs, including 33 ultra-deepwater drillships,...

Continue reading

Form 8.3 – [IDOX PLC – 06 02 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Form 8.3 – [INSPECS GROUP PLC – 06 02 2026] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree INSPECS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

Press Release dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, today announces it has entered into an agreement with CVC, a leading global private markets manager, to divest its Animal Nutrition & Health (“ANH”) business for an enterprise value of about €2.2 billion, which includes an earnout of up to €0.5 billion. dsm-firmenich will retain a 20% equity stake in the divested ANH Companies, in partnership with CVC. This transaction follows the sale of the Feed Enzymes activities to Novonesis for €1.5 billion in 2025 and marks the final strategic step for dsm-firmenich to become a fully focused consumer company active in nutrition, health, and beauty. The...

Continue reading

Onex Completes Convex Acquisition and Strategic Investment by AIG

Key drivers of strategy to enhance Onex’ enterprise value through Convex ownership and increased profitability at Onex’ asset management platform All amounts in U.S. dollars unless otherwise stated TORONTO, Feb. 06, 2026 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced the completion of its previously announced acquisition of Convex Group Limited (“Convex”), a leading specialty property and casualty insurance and reinsurance company. “This is a pivotal moment in Onex’ history and the addition of Convex positions us well for accelerated value creation and earnings growth,” said Onex CEO Bobby Le Blanc. “What the Convex team has achieved in just seven years since they founded the business is remarkable, and I am confident that considerable upside lies ahead. With world-class underwriting talent, low asset leverage,...

Continue reading

Veeco Stockholders Approve Merger with Axcelis

PLAINVIEW, N.Y., Feb. 06, 2026 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (Nasdaq: VECO) (“Veeco”) today announced that its stockholders have voted to approve all proposals related to the Company’s pending merger (the “Merger”) with Axcelis Technologies, Inc. (Nasdaq: ACLS) (“Axcelis”) at its Special Meeting of Stockholders (“Special Meeting”). The final voting results of the Special Meeting will be reported in a Form 8-K filed by Veeco with the U.S. Securities and Exchange Commission. The completion of the Merger remains subject to other customary closing conditions, including the final pending regulatory approval from the State Administration for Market Regulation of the People’s Republic of China. Veeco and Axcelis continue to expect that the Merger will be completed in the second half of 2026. About VeecoVeeco (NASDAQ: VECO)...

Continue reading

SRx Health Solutions Launches EventHorizonIQ, a Public Ledger of AI-Generated Financial Market Instability Signals

NORTH PALM BEACH, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, announced the public launch of EventHorizonIQ, a read-only, append-only ledger designed to record early signs of financial market instability generated by artificial intelligence agents, as a core component of EMJX’s broader effort to build AI-driven financial infrastructure. EventHorizonIQ publishes a limited number of system-level signals intended to reflect underlying market conditions rather than prices, forecasts, or trading recommendations. Signals are generated exclusively by AI agents, expressed as discrete states, and permanently...

Continue reading

Refresco To Acquire SunOpta For $6.50 Per Share In Cash

                 FOR IMMEDIATE RELEASE REFRESCO TO ACQUIRE SUNOPTA FOR $6.50 PER SHARE IN CASH Strategic combination expands Refresco’s North American capabilities SunOpta common stockholders to receive $6.50 per share in cash Expected to close in the second quarter of 2026, subject to customary closing conditions Rotterdam, the Netherlands and Minneapolis, Minnesota – February 6, 2026 – Refresco, the leading independent beverage solutions provider for preeminent global and local beverage brands in North America, Europe, and Australia, and SunOpta Inc. (“SunOpta”) (Nasdaq: STKL) (TSX:SOY), a North American supply chain solutions provider, today announced that they have entered into a definitive agreement under which Refresco has agreed to acquire SunOpta for $6.50 per share in cash. Steve Presley, Chief Executive Officer of Refresco,...

Continue reading

SPX Technologies Completes Acquisition of Crawford United

Expands SPX Technologies’ HVAC Capabilities with Highly Engineered Custom Air-Handling Solutions CHARLOTTE, N.C., Feb. 06, 2026 (GLOBE NEWSWIRE) — SPX Technologies, Inc. (NYSE: SPXC) (“SPX” or the “Company”) announced today that it has completed its acquisition of Crawford United Corporation (OTC: CRAWA) (“Crawford United”), a Cleveland-based holding company with a broad portfolio of highly engineered air handling and industrial products. Crawford United’s shareholders voted in support of the transaction and, pursuant to the merger agreement governing the transaction, Crawford United was merged with a subsidiary of SPX, with holders of Class A and Class B common stock of Crawford United being entitled to receive, after adjustments for satisfaction of indebtedness and payment of expenses, cash consideration of approximately $83.86 per...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.